SCHEMBL18828985

SCHEMBL18828985

COC(=O)c1ccc2[nH]nc(NC(=NO)c3ccccc3)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 5/20 0.49
FLT3 P36888 1/20 0.47
GSK3B P49841 2/20 0.46
GSK3A P49840 1/20 0.46
GPR84 Q9NQS5 1/20 0.46
KDM4E B2RXH2 2/20 0.45
STAT3 P40763 1/20 0.45
HIF1A Q16665 1/20 0.45
JAK2 O60674 2/20 0.44
JAK1 P23458 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
ULK1 O75385 1/20 0.44
CDK2 P24941 2/20 0.43
KIF11 P52732 1/20 0.43
HPGD P15428 2/20 0.43
F2 P00734 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18828986 1.00 CDK7 (0.49) CDK7FLT3GSK3BGSK3AGPR84
SCHEMBL18812687 1.00 CDK7 (0.49) CDK7FLT3GSK3BGSK3AGPR84
SCHEMBL18812678 0.89 CDK7 (0.48) CDK7GSK3BGSK3AJAK2JAK1
SCHEMBL18828988 0.89 CDK7 (0.48) CDK7GSK3BGSK3AJAK2JAK1
SCHEMBL18828989 0.89 CDK7 (0.48) CDK7GSK3BGSK3AJAK2JAK1
SCHEMBL18932071 0.86 CDK7 (0.49) CDK7FLT3GSK3BGSK3AGPR84
SCHEMBL18828963 0.81 FLT3 (0.60) FLT3GSK3BKDM4ESTAT3HIF1A
SCHEMBL18828964 0.81 FLT3 (0.60) FLT3GSK3BKDM4ESTAT3HIF1A
SCHEMBL18812671 0.81 FLT3 (0.60) FLT3GSK3BKDM4ESTAT3HIF1A
SCHEMBL18828978 0.80 MAPK10 (0.52) FLT3KMT2ACDK2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170158642-A1 COMPOSITION FOR INDUCING CELL REPROGRAMMING GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-06-08 US disclosed
EP-3165523-A2 COMPOSITION FOR INDUCING CELL REPROGRAMMING Gwangju Institute of Science and Technology (KR) 2017-05-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158642-A1 COMPOSITION FOR INDUCING CELL REPROGRAMMING MCL1, IRF3, STING1 CDK7 653/4885FLT3 357/4885GSK3B 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.